<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>427</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15634921</PubmedId>
            <Abstract>Peptide mimics of a conformational epitope that is recognized by a mAb with antitumor activity are promising candidates for formulations of anticancer vaccines. These mimotope vaccines are able to induce a polyclonal Ab response focused to the determinant of the mAb. Such attempts at cancer immunotherapy are of special interest for malignant melanoma that is highly resistant to chemotherapy and radiotherapy. In this study, we describe for the first time the design and immunogenicity of a vaccine containing a mimotope of the human high m.w. melanoma-associated Ag (HMW-MAA) and the biological potential of the induced Abs. Mimotopes were selected from a pVIII-9mer phage display peptide library with the anti-HMW-MAA mAb 225.28S. The mimotope vaccine was then generated by coupling the most suitable candidate mimotope to tetanus toxoid as an immunogenic carrier. Immunization of rabbits with this vaccine induced a specific humoral immune response directed toward the epitope recognized by the mAb 225.28S on the native HMW-MAA. The induced Abs inhibited the in vitro growth of the melanoma cell line 518A2 up to 62%. In addition, the Abs mediated 26% lysis of 518A2 cells in Ab-dependent cellular cytotoxicity. Our results indicate a possible application of this mimotope vaccine as a novel immunotherapeutic agent for the treatment of malignant melanoma.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>976-82</ArticlePages>
            <ArticleTitle>Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Wagner</LastName>
                    <ForeName>Stefan</ForeName>
                </Author>
                <Author>
                    <LastName>Hafner</LastName>
                    <ForeName>Christine</ForeName>
                </Author>
                <Author>
                    <LastName>Allwardt</LastName>
                    <ForeName>Dorothee</ForeName>
                </Author>
                <Author>
                    <LastName>Jasinska</LastName>
                    <ForeName>Joanna</ForeName>
                </Author>
                <Author>
                    <LastName>Ferrone</LastName>
                    <ForeName>Soldano</ForeName>
                </Author>
                <Author>
                    <LastName>Zielinski</LastName>
                    <ForeName>Christoph C</ForeName>
                </Author>
                <Author>
                    <LastName>Scheiner</LastName>
                    <ForeName>Otto</ForeName>
                </Author>
                <Author>
                    <LastName>Wiedermann</LastName>
                    <ForeName>Ursula</ForeName>
                </Author>
                <Author>
                    <LastName>Pehamberger</LastName>
                    <ForeName>Hubert</ForeName>
                </Author>
                <Author>
                    <LastName>Breiteneder</LastName>
                    <ForeName>Heimo</ForeName>
                </Author>
            </Authors>
            <Affiliations>Bio Life Science, Vienna, Austria.</Affiliations>
            <ArticleChemicalList>Antibodies, Anti-Idiotypic;Antibodies, Neoplasm;Antigens, Neoplasm;Epitopes;Growth Inhibitors;Melanoma-Specific Antigens;Neoplasm Proteins;Peptide Library;Tetanus Toxin;Vaccines, Subunit;Viral Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Anti-Idiotypic(immunology; metabolism); Antibodies, Neoplasm(biosynthesis; metabolism); Antibody Specificity; Antibody-Dependent Cell Cytotoxicity(immunology); Antigens, Neoplasm; Binding Sites, Antibody; Cell Line, Tumor; Epitopes(administration &amp; dosage; immunology; metabolism); Growth Inhibitors(administration &amp; dosage; immunology; metabolism); Humans; Melanoma(immunology; pathology; prevention &amp; control); Melanoma-Specific Antigens; Molecular Mimicry(immunology); Molecular Sequence Data; Molecular Weight; Neoplasm Proteins(administration &amp; dosage; immunology); Peptide Library; Rabbits; Tetanus Toxin(administration &amp; dosage; immunology; metabolism); Vaccines, Subunit(administration &amp; dosage; immunology; metabolism); Viral Proteins(immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>174</Volume>
                <Issue>2</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>225D9.2+</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is a mimotope of:</RelatedObjectType>
                    <RelatedObject>
                        <AccessionSequenceMolecule>
                            <ChemicalType>Protein</ChemicalType>
                            <Molecule>
                                <GenBankId>P04626.1</GenBankId>
                            </Molecule>
                            <SourceOrganismId>9606</SourceOrganismId>
                        </AccessionSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>66108</EpitopeId>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The epitope is the sequence of a 9-mer peptide (225D9.2 = TRTNPWPAL) derived from a peptide library with 5 additional amino acids (+ = AEGEF) representing the N-terminal sequence of pVIII phage (major coat protein).  The mimotope mimics an epitope on human high m.w. melanoma-associated antigen (HMW-MAA) and was selected with an anti-HMW-MAA mAb 225.28S) from a pVIII-9mer phage display library (composed of random 9 aa residues displayed on filamentous phage as fusion to the amino terminus of the major coat protein).</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>5525</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>225D9.2+</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA23282.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>14-21 day intervals; animals sacrificed 7 days after last immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Antibody binding (OD) was measured with increasing anti-mimotope IgG concentrations in a competition assay between the epitope (225D9.2+, competitor) and the anti-idiotypic antibody (mAb MF11-30, solid phase).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>225D9.2+</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>5526</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>225D9.2+</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA23282.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>14-21 day intervals; animals sacrificed 7 days after last immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The inhibition of growth of a melanoma cell line 518A2 (positive for HMW-MAA) with purified anti-mimotope IgGs was measured.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>melanoma-associated chondroitin sulfate proteoglycan (MCSP)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Structurally Related</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>CAA65529.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>1634</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>225D9.2+</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA23282.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>14-21 day intervals; animals sacrificed 7 days after last immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Antibody binding (OD) with increasing anti-mimotope IgG concentrations was measured.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>225D9.2+</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <SequenceMoleculeNoNaturalSource>
                                        <ChemicalType>Peptide, no natural source</ChemicalType>
                                        <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                    </SequenceMoleculeNoNaturalSource>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <IedbAccession>SRC40074</IedbAccession>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>1646</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>225D9.2+</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA23282.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>14-21 day intervals; animals sacrificed 7 days after last immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>148</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Killing of melanoma cell line 518A2 (positive for HMW-MAA) by PBMCs stimulated with purified anti-mimotope IgGs was measured.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>melanoma-associated chondroitin sulfate proteoglycan (MCSP)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Structurally Related</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>CAA65529.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1635</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <SequenceMoleculeNoNaturalSource>
                                            <ChemicalType>Peptide, no natural source</ChemicalType>
                                            <LinearSequence>TRTNPWPALAEGEF</LinearSequence>
                                        </SequenceMoleculeNoNaturalSource>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>225D9.2+</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAA23282.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>1513</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>14-21 day intervals; animals sacrificed 7 days after last immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Antibody binding (OD) with increasing anti-mimotope IgG concentrations was measured.  The antigen is contained in human melanoma cell line (518A2) lysates.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>melanoma-associated chondroitin sulfate proteoglycan (MCSP)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>CAA65529.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

